SCHEMBL9788862

SCHEMBL9788862

C=CCc1ccccc1OCOc1ccccc1CC=C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 3/20 0.55
HTR1A P08908 2/20 0.53
ADRA2C P18825 2/20 0.53
ADRA2A P08913 1/20 0.53
ADRA2B P18089 1/20 0.53
NISCH Q9Y2I1 1/20 0.53
ADRB2 P07550 5/20 0.51
ADRB1 P08588 4/20 0.51
LMNA P02545 2/20 0.51
ADRB3 P13945 2/20 0.51
SLC6A2 P23975 1/20 0.51
BDKRB2 P30411 1/20 0.51
SLC6A4 P31645 1/20 0.51
ADRA1A P35348 1/20 0.51
HTR2B P41595 1/20 0.51
KCNH2 Q12809 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9625908 0.88 KDM4E (0.69) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL12227223 0.88 KDM4E (0.64) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL5085750 0.86 ALDH1A1 (0.54) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL173232 0.86 KDM4E (0.54) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL9626411 0.86 KDM4E (0.67) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL9625662 0.86 KDM4E (0.67) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL9627195 0.86 KDM4E (0.67) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL9625872 0.86 KDM4E (0.67) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL3255815 0.84 ALDH1A1 (0.56) KDM4EALDH1A1HTR1AADRA2CADRA2A
SCHEMBL7901091 0.84 ALDH1A1 (0.55) KDM4EALDH1A1HTR1AADRA2CADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0054488-B1 USE OF DI(ALKYLPHENOXY) METHANES AS ISOLATING OILS, AND DI(ALKYLPHENOXY) METHANE WHICH CAN BE USED FOR THIS APPLICATION COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) 1984-02-15 EP claimed
US-8043534-B2 An adhesive comprising a maleimide and an aromatic diene or an aromatic monoene which cure to form useful thermosetting resins for the microelectronic packaging industry; semiconcuctor dies; addition polymerization/Diels-Alder reaction; heat and acid resistance; toughness; noncracking; nondestructive DESIGNER MOLECULES, INC. (US) 2011-10-25 US disclosed
US-8043534-B2 An adhesive comprising a maleimide and an aromatic diene or an aromatic monoene which cure to form useful thermosetting resins for the microelectronic packaging industry; semiconcuctor dies; addition polymerization/Diels-Alder reaction; heat and acid resistance; toughness; noncracking; nondestructive DESIGNER MOLECULES, INC. (US) 2011-10-25 US disclosed
US-20080075965-A1 Maleimide compositions and methods for use thereof DESIGNER MOLECULES, INC. 2008-03-27 US disclosed
US-20080075965-A1 Maleimide compositions and methods for use thereof DESIGNER MOLECULES, INC. 2008-03-27 US disclosed
US-5001294-A Synthesis of diaryl alkenes HAY ALLAN S (CA) 1991-03-19 US disclosed
EP-0054488-B1 USE OF DI(ALKYLPHENOXY) METHANES AS ISOLATING OILS, AND DI(ALKYLPHENOXY) METHANE WHICH CAN BE USED FOR THIS APPLICATION COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) 1984-02-15 EP disclosed
EP-0054488-A1 Use of di(alkylphenoxy) methanes as isolating oils, and di(alkylphenoxy) methane which can be used for this application COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) 1982-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080075965-A1 Maleimide compositions and methods for use thereof KDM4E, MLLT1, DOT1L KDM4E 1/4885ALDH1A1 769/4885HTR1A 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.